MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03893cam a2200337 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
9781118863275 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
180406t2015 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781118863275 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1118863275 (epub) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781118863268 (pdf) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1118863267 (pdf) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781118863282 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1118863283 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1118863321 (cloth) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781118863329 (cloth) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
(cloth) |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Savani, Bipin N. (ed) |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Clinical guide to transplantation in lymphoma |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Chichester, West Sussex; Hoboken, NJ : |
| Name of publisher, distributor, etc. |
John Wiley and Sons, Inc., |
| Date of publication, distribution, etc. |
2015 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource. : (epub) |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
text |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Title page; Table of Contents; List of contributors; Foreword; Introduction; Declaration of commercial interest; References; Section 1: Transplantation in lymphomas; Chapter 1: Lymphoma and transplantation: historical perspective; Brief history of hematopoietic cell transplantation; History of autologous HCT in non-Hodgkin lymphoma; History of autologous HCT in Hodgkin lymphoma; History of allogeneic HCT in lymphoma; General historical considerations; References; Chapter 2: Lymphoma: working committee and data reporting after transplantation in lymphoma; Introduction; Registry structure |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Data reportingOvercoming challenges to data reporting; Data quality; The Lymphoma Working Committee; Statistical methods; Selected examples from the CIBMTR Lymphoma Committee; Value for young investigators; Value for public and other stakeholders; Conclusion; References; Chapter 3: Use of transplantation in lymphoma: adults; Introduction; Hodgkin lymphoma; Non-Hodgkin lymphoma; Prognostic tools; Maintenance therapies; Novel therapies; Conclusions; References; Chapter 4: Hematopoietic stem cell transplantation for lymphoma in children, adolescents, and young adults; Introduction |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Principles of autologous and allogeneic HSCT in pediatric lymphomasHodgkin lymphoma; Lymphoblastic lymphoma; Anaplastic large-cell lymphoma; Mature B-cell lymphomas: Burkitt lymphoma, diffuse large B-cell lymphoma, and primary mediastinal B-cell lymphoma; Future directions; Conclusions; References; Chapter 5: Preparative regimens for lymphoma: autologous hematopoietic stem cell transplantation; Rationale for chemotherapy dose intensification for disease eradication; Traditional preparative regimens; Incorporation of monoclonal antibodies in autologous HCT preparative regimens |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Novel agents used in preparative regimensFuture directions; References; Chapter 6: Preparative regimens for lymphoma: allogeneic hematopoietic stem cell transplantation; Introduction; Myeloablative conditioning regimens for lymphomas; Reduced-intensity conditioning regimens; Incorporating monoclonal antibodies in preparative regimens for allo-HCT; Alternative donor sources; Discussion and future direction; References; Chapter 7: Pretransplantation evaluation, comorbidities, and nondisease-related eligibility criteria for transplantation in lymphoma; Introduction; Initial steps |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Preparation for transplant center evaluationTransplant center evaluation; Post-evaluation review and final pretransplant process; References; Chapter 8: Stem cell mobilization in lymphoma patients; Introduction; Methods for mobilization; Stem cell collection and apheresis; Poor mobilizers and mobilization failure; Special populations; Complications; Future considerations; References; Chapter 9: Allogeneic hematopoietic stem cell transplantation for lymphoma: stem cell source, donor, and HLA matching; Historical perspective; Rationale for allogeneic transplantation; Stem cell source |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Remote |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Includes bibliographical references and index. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Mohty, Mohamad (ed) |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="http://dx.doi.org/10.1002/9781118863282">http://dx.doi.org/10.1002/9781118863282</a> |
| Link text |
[Wiley Online Library] |